Please select the option that best describes you:

In a patient who requires prostate cytoreduction prior to EBRT or brachytherapy, do you include a 5-alpha reductase inhibitor in your ADT regimen?  



Answer from: Radiation Oncologist at Academic Institution
Sign in or Register to read more